Editas Medicine clears first-in-human trial of EDIT-401 in Australia
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: EDIT) | Delayed: 2.38 -0.11 (4.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.49 | 52 Week High | $43.99 | |||
| Open | $2.44 | 52 Week Low | $12.43 | |||
| Day High | $2.45 | P/E | N/A | |||
| Day Low | $2.30 | EPS | $0.00 | |||
| Volume | 747,241 | |||||
